Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT

Whitney F. Handy, Keith T. Schmidt, Douglas K. Price, William D. Figg*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT'. Together they form a unique fingerprint.

Medicine & Life Sciences